Faculty Member, Malignant Hematology and Cellular Therapy Hematologist

Location
Tampa, Florida
Salary
Negotiable
Posted
Jul 12, 2019
Closes
Aug 11, 2019
Hours
Full Time

The Moffitt Cancer Center is seeking a faculty member to join its Malignant Hematology and Cellular    Therapy (MHCT) Program at Memorial Health System in Pembroke Pines and Hollywood, FL.  The faculty member joins the MHCT Team to provide medical treatment to patients with malignant hematologic disorders and should be able to gain privileges for Bone Marrow Transplantation.  A physician with desired focus of Myeloma is preferred.  Faculty member will also serve as a member of the Moffitt Medical Group. The position involves all aspects of patient care, including the evaluation, management, and treatment of patients. The position demonstrates an interdisciplinary approach to treating cancer and works with several specialists to optimize patient care delivery.

Candidates must be BC/BE, board certified in specialty, fellowship trained in Oncology, Hematology or Hematology / Oncology and completed requirements for ABIM Certification in Internal Medicine, Florida Medical Licensure, DEA Licensure. The successful applicant will have clinical and research leadership skills.   

Moffitt Cancer Center & Research Institute, the only NCI-designated Comprehensive Cancer Center in Florida, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999.  Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer.

Memorial Healthcare System is one of the largest public healthcare systems in the country and a national leader in quality care and patient satisfaction, highly regarded for its exceptional patient-and family-centered care. The Malignant Hematology and Cellular Therapy Program is located at the Memorial Hospital West Campus with a 33-bed inpatient unit, a 7-bed IPOP unit (with planned expansion) and Outpatient clinical operations for the program.